Major histocompatibility complex (MHC) molecules display small protein fragments called peptides. T cells recognize these peptide–MHC complexes through their T-cell receptors. In humans, MHC molecules are called HLA—human leukocyte antigens.
Proteases break down proteins in acidified compartments.
→
Peptide loading
HLA-DM supports peptide exchange on MHC II after invariant-chain processing.
→
Cell surface
Peptide–MHC II complexes reach the surface for CD4+ T-cell recognition.
An important exception
Dendritic cells can present peptides from captured extracellular antigens on MHC I through cross-presentation. This helps prime CD8+ T-cell responses. MHC II can also receive some intracellular proteins through additional pathways.
Recognition is only the first step
Activation of naive T cells usually also requires co-stimulatory signals and an appropriate cytokine environment. Recognition alone does not guarantee an effective immune response.
MHC & Aging
Aging can alter antigen uptake, processing, dendritic-cell signaling and T-cell priming. Findings vary with cell type, tissue and experimental conditions.
More than MHC levels
MHC expression alone does not reveal how effectively a cell presents antigen. Co-stimulation, cytokines and T-cell function also matter.
Age-related changes in antigen presentation are not a uniform decline in MHC expression.